Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2123262 | 0.74 | KMT2A (0.40) | ALDH1A1CA2 | |
| SCHEMBL6929900 | 0.74 | CA2 (0.44) | ALDH1A1CA2 | |
| SCHEMBL9013457 | 0.70 | — | — | |
| SCHEMBL3444537 | 0.70 | CASP1 (0.35) | CA2 | |
| SCHEMBL11130077 | 0.69 | CA2 (0.38) | ALDH1A1CA2 | |
| SCHEMBL9965492 | 0.69 | HSD11B1 (0.47) | ALDH1A1CA2 | |
| SCHEMBL17289107 | 0.69 | CA1 (0.34) | ALDH1A1CA2 | |
| SCHEMBL8054555 | 0.69 | ALDH1A1 (0.36) | ALDH1A1CA2 | |
| SCHEMBL447764 | 0.68 | ALDH1A1 (0.37) | ALDH1A1CA2 | |
| SCHEMBL6264610 | 0.67 | CA2 (0.43) | ALDH1A1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2239057-B1 | Asymmetric catalyst and process for preparing optically active alcohols using the same | KANTO KAGAKU (JP) | 2015-06-03 | — | — | EP | disclosed |
| US-8232420-B2 | Asymmetric catalyst and process for preparing optically active alcohols using the same | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2012-07-31 | — | — | US | disclosed |
| US-20100261924-A1 | ASYMMETRIC CATALYST AND PROCESS FOR PREPARING OPTICALLY ACTIVE ALCOHOLS USING THE SAME | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2010-10-14 | — | — | US | disclosed |
| EP-2239057-A1 | Asymmetric catalyst and process for preparing optically active alcohols using the same | Kanto Kagaku Kabushiki Kaisha (JP) | 2010-10-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100261924-A1 | ASYMMETRIC CATALYST AND PROCESS FOR PREPARING OPTICALLY ACTIVE ALCOHOLS USING THE SAME | ADH1A, ADH1C, ADH5 | ALDH1A1 80/4885CA2 826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.